These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 31686946)

  • 1. Orphan Drugs In Development For The Treatment Of Friedreich's Ataxia: Focus On Omaveloxolone.
    Ghanekar SD; Miller WW; Meyer CJ; Fenelon KJ; Lacdao A; Zesiewicz TA
    Degener Neurol Neuromuscul Dis; 2019; 9():103-107. PubMed ID: 31686946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel Nrf2-Inducer Prevents Mitochondrial Defects and Oxidative Stress in Friedreich's Ataxia Models.
    Abeti R; Baccaro A; Esteras N; Giunti P
    Front Cell Neurosci; 2018; 12():188. PubMed ID: 30065630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and pharmacodynamics of the novel Nrf2 activator omaveloxolone in primates.
    Reisman SA; Gahir SS; Lee CI; Proksch JW; Sakamoto M; Ward KW
    Drug Des Devel Ther; 2019; 13():1259-1270. PubMed ID: 31118567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Omaveloxolone: First Approval.
    Lee A
    Drugs; 2023 Jun; 83(8):725-729. PubMed ID: 37155124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of Omaveloxolone in Friedreich's Ataxia: Delayed-Start Analysis of the MOXIe Extension.
    Lynch DR; Chin MP; Boesch S; Delatycki MB; Giunti P; Goldsberry A; Hoyle JC; Mariotti C; Mathews KD; Nachbauer W; O'Grady M; Perlman S; Subramony SH; Wilmot G; Zesiewicz T; Meyer CJ
    Mov Disord; 2023 Feb; 38(2):313-320. PubMed ID: 36444905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Friedreich's Ataxia: A Neuronal Point of View on the Oxidative Stress Hypothesis.
    Carletti B; Piemonte F
    Antioxidants (Basel); 2014 Sep; 3(3):592-603. PubMed ID: 26785073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and Efficacy of Omaveloxolone in Friedreich Ataxia (MOXIe Study).
    Lynch DR; Chin MP; Delatycki MB; Subramony SH; Corti M; Hoyle JC; Boesch S; Nachbauer W; Mariotti C; Mathews KD; Giunti P; Wilmot G; Zesiewicz T; Perlman S; Goldsberry A; O'Grady M; Meyer CJ
    Ann Neurol; 2021 Feb; 89(2):212-225. PubMed ID: 33068037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
    Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
    J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of mitochondrial DNA variations among Indian Friedreich's ataxia (FRDA) patients.
    Singh I; Faruq M; Padma MV; Goyal V; Behari M; Grover A; Mukerji M; Srivastava AK
    Mitochondrion; 2015 Nov; 25():1-5. PubMed ID: 26321457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic Prospects for Friedreich's Ataxia.
    Zhang S; Napierala M; Napierala JS
    Trends Pharmacol Sci; 2019 Apr; 40(4):229-233. PubMed ID: 30905359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug repositioning screening identifies etravirine as a potential therapeutic for friedreich's ataxia.
    Alfedi G; Luffarelli R; Condò I; Pedini G; Mannucci L; Massaro DS; Benini M; Toschi N; Alaimo G; Panarello L; Pacini L; Fortuni S; Serio D; Malisan F; Testi R; Rufini A
    Mov Disord; 2019 Mar; 34(3):323-334. PubMed ID: 30624801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenosine Improves Mitochondrial Function and Biogenesis in Friedreich's Ataxia Fibroblasts Following L-Buthionine Sulfoximine-Induced Oxidative Stress.
    Lew SY; Mohd Hisam NS; Phang MWL; Syed Abdul Rahman SN; Poh RYY; Lim SH; Kamaruzzaman MA; Chau SC; Tsui KC; Lim LW; Wong KH
    Biology (Basel); 2023 Apr; 12(4):. PubMed ID: 37106759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting lipid peroxidation and mitochondrial imbalance in Friedreich's ataxia.
    Abeti R; Uzun E; Renganathan I; Honda T; Pook MA; Giunti P
    Pharmacol Res; 2015 Sep; 99():344-50. PubMed ID: 26141703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heart disease in Friedreich's ataxia.
    Hanson E; Sheldon M; Pacheco B; Alkubeysi M; Raizada V
    World J Cardiol; 2019 Jan; 11(1):1-12. PubMed ID: 30705738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Friedreich's Ataxia (FRDA) is an extremely rare cause of autosomal recessive ataxia in Chinese Han population.
    Zeng J; Wang J; Zeng S; He M; Zeng X; Zhou Y; Liu Z; Jiang H; Tang B
    J Neurol Sci; 2015 Apr; 351(1-2):124-126. PubMed ID: 25765228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thioredoxin and Glutaredoxin Systems as Potential Targets for the Development of New Treatments in Friedreich's Ataxia.
    Seco-Cervera M; González-Cabo P; Pallardó FV; Romá-Mateo C; García-Giménez JL
    Antioxidants (Basel); 2020 Dec; 9(12):. PubMed ID: 33321938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular analysis of Friedreich's ataxia locus in the Indian population.
    Mukerji M; Choudhry S; Saleem Q; Padma MV; Maheshwari MC; Jain S
    Acta Neurol Scand; 2000 Oct; 102(4):227-9. PubMed ID: 11071107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does oxidative stress contribute to the pathology of Friedreich's ataxia? A radical question.
    Armstrong JS; Khdour O; Hecht SM
    FASEB J; 2010 Jul; 24(7):2152-63. PubMed ID: 20219987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial dysfunction in friedreich's ataxia.
    Lodi R; Taylor DJ; Schapira AH
    Biol Signals Recept; 2001; 10(3-4):263-70. PubMed ID: 11351132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficient attenuation of Friedreich's ataxia (FRDA) cardiomyopathy by modulation of iron homeostasis-human induced pluripotent stem cell (hiPSC) as a drug screening platform for FRDA.
    Lee YK; Lau YM; Ng KM; Lai WH; Ho SL; Tse HF; Siu CW; Ho PW
    Int J Cardiol; 2016 Jan; 203():964-71. PubMed ID: 26625322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.